Chemoinformaics analysis of Gamma-L-Glutamyl-L-Valine
| Molecular Weight | 246.263 | nRot | 7 |
| Heavy Atom Molecular Weight | 228.119 | nRig | 3 |
| Exact Molecular Weight | 246.122 | nRing | 0 |
| Solubility: LogS | -1.545 | nHRing | 0 |
| Solubility: LogP | -3.081 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 34.9123 |
| nHD | 4 | BPOL | 20.6617 |
| QED | 0.474 |
| Synth | 2.747 |
| Natural Product Likeliness | 0.387 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.163 |
| HIA | 0.053 |
| CACO-2 | -6.228 |
| MDCK | 0.00540804 |
| BBB | 0.573 |
| PPB | 0.0890789 |
| VDSS | 0.345 |
| FU | 0.777914 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.019 |
| CYP2c19-inh | 0.043 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.682 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.018 |
| CL | 4.157 |
| T12 | 0.683 |
| hERG | 0.009 |
| Ames | 0.011 |
| ROA | 0.007 |
| SkinSen | 0.148 |
| Carcinogencity | 0.012 |
| EI | 0.037 |
| Respiratory | 0.055 |
| NR-Aromatase | 0.003 |
| Antiviral | No |
| Prediction | 0.838338 |